
Keywords: 95% CI, 95% Confidence Interval; DMT, disease-modifying therapy; FG, fingolimod; FSS, Fatigue Severity Scale; GA, glatiramer acetate; ICF, informed consent forms; IFNβ, interferon beta; MPR, medication possession ratio; NZ, natalizumab; OR, Odds Ratio; PD